{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "ad84b562-8d5c-444b-8e15-3f34a826f8d5", "code": "A10BD03", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and rosiglitazone", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD03&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "7c503346-7f90-41bf-8be7-734be78c3898", "code": "A10BD05", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and pioglitazone", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD05&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "a381c754-aa6e-4198-b9a6-98f43ab96625", "code": "A10BD07", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and sitagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD07&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "a1ab7c3a-ca25-4654-9a43-dabecc6f3324", "code": "A10BD11", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and linagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD11&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "af91c568-5b10-487a-a00b-4a15e810e33d", "code": "A10BD08", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and vildagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD08&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "4d8aee4e-6360-416e-94a6-cb01fe8f67bf", "code": "A10BD10", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and saxagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD10&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "957ddbfb-7c5b-4238-ab74-164dd6115633", "code": "A10BD13", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and alogliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD13&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "7af00f65-78cc-41cd-bdde-8cd43b951a0e", "code": "A10BD14", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and repaglinide", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD14&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "a7e880ce-1fa5-462c-9ee9-4f4945e63960", "code": "A10BD15", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and dapagliflozin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD15&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "684c022c-1604-4990-b109-2a031f2bc125", "code": "SUB08831MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "7b1a4889-1430-4d1e-b7df-7da4cb67233e", "code": "965", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=965", "code_system": "INN", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "91d9213b-8400-44a4-929a-8a272f1abb9b", "code": "211-517-8", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.010.472", "code_system": "ECHA (EC/EINECS)", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "295e5759-ecd2-4873-8431-76ad4e0292c2", "code": "4779", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4779", "code_system": "IUPHAR", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "9c47262e-71a5-4cf9-994a-f82fcd937071", "code": "6809", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/6809/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "947fccdf-f74c-4d35-9ff8-5b71735e3d34", "code": "m7280", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m7280?q=authorize", "code_system": "MERCK INDEX", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "71c60c36-86fc-45c9-9438-2814b998322d", "code": "DB00331", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00331", "code_system": "DRUG BANK", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "7c38dfe2-75e7-4266-883f-851098ca591d", "code": "CHEMBL1431", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1431", "code_system": "ChEMBL", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "ec62c230-135a-47b2-a2c0-d493cce08bad", "code": "A10BD16", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and canagliflozin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD16&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "78108a75-ebd3-4ff3-8170-7cd54ad0b15b", "code": "A10BD17", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and acarbose", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD17&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "ffc42aae-22a6-4958-92fd-2c8a131bb2e7", "code": "A10BD18", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and gemigliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD18&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "9a246a6b-f930-4a9e-b802-901f14c3a95b", "code": "A10BD20", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and empagliflozin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD20&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "23abbd4e-682a-4bcd-ada7-b03c3e6f4f8b", "code": "4091", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4091", "code_system": "PUBCHEM", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "4b4b2782-ff4f-4e0d-8078-559d1c32db80", "code": "A10BA02", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Biguanides|metformin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BA02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "53e3c9e5-b406-4d79-8601-cba0564950eb", "code": "N0000175565", "comments": "Established Pharmacologic Class [EPC]|Biguanide [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175565", "code_system": "NDF-RT", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "bad0a322-5d15-4ce2-be0e-53960b55ebd7", "code": "N0000007698", "comments": "Chemical Ingredients [Chemical/Ingredient]|Organic Chemicals [Chemical/Ingredient]|Amidines [Chemical/Ingredient]|Guanidines [Chemical/Ingredient]|Biguanides [Chemical/Ingredient]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000007698", "code_system": "NDF-RT", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "03df78fb-17a8-44ee-a0e1-3d51e0c3d899", "code": "QA10BD15", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and dapagliflozin", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD15&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "d6c9d532-393e-4ec1-a8c3-2589cdbca8c0", "code": "QA10BD14", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and repaglinide", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD14&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "3c6d3df2-9a8a-4eff-bd24-8c40f5577fe2", "code": "QA10BD13", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and alogliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD13&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "8c6a4632-16d3-40a7-b68a-3de1a4a84c29", "code": "QA10BD11", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and linagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD11&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "e0738b10-13a3-4ee0-95c9-956d4614b252", "code": "QA10BD10", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and saxagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD10&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "c7fbf936-27f4-40da-ac73-dc18877610da", "code": "QA10BD02", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and sulfonamides", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "2acf3a6c-cb48-4259-a029-15953d0a30cc", "code": "QA10BD03", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and rosiglitazone", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD03&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "fcb4d0c9-6aa5-4218-bb96-6b17322514a9", "code": "QA10BD05", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and pioglitazone", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD05&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "1a7175df-b3f0-4e94-97d4-10b51231e3b5", "code": "QA10BD07", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and sitagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD07&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "7435096a-8520-460c-9244-aee399d6062c", "code": "QA10BD08", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and vildagliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BD08&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "95fd6d97-d59d-4acc-b09e-ae5849207cf7", "code": "QA10BA02", "comments": "VATC|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Biguanides|metformin", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA10BA02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "7e48aafb-12e7-41ee-ae04-62b16923544d", "code": "657-24-9", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=657-24-9", "code_system": "CAS", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724", "30007789-8725-4812-8e59-f300fe907714" ] }, { "uuid": "89126abd-f288-439e-afa9-3e21befbf33a", "code": "C61612", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61612", "code_system": "NCI_THESAURUS", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "86210b3e-d52f-4364-8d45-7d8a5219a95a", "code": "D008687", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68008687", "code_system": "MESH", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "03e3ae01-4970-4fd4-90e9-e6d07dab840d", "code": "NBK548726", "comments": "LiverTox|Endocrine|Diabetes|Biguanide", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548726/", "code_system": "LIVERTOX", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "92190f77-1751-41fa-b1e7-d7001e85c336", "code": "METFORMIN", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Metformin", "code_system": "WIKIPEDIA", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "17ef4c2e-4a39-421f-9b8c-5e8d3bc87400", "code": "18.5", "comments": "WHO ESSENTIAL MEDICINES LIST|Hormones, other endocrine medicines and contraceptives|Insulins and other medicines used for diabetes", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/282/?section=129#type648", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "346e96a0-2d0d-4f5b-806d-42e27727c484", "code": "A10BD02", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and sulfonamides", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "8ef15da9-330c-4ea7-830f-8becdaee8724" ] }, { "uuid": "e752f7f7-d205-a770-d979-8dddafa67d0a", "code": "DTXSID2023270", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID2023270", "code_system": "EPA CompTox", "references": [ "5bc41add-c905-c2eb-4bca-fa72e83fdc42" ] }, { "uuid": "96d6a630-e489-8bfd-efad-ab1def9f7112", "code": "Metformin", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM173/", "code_system": "LACTMED", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "a2d98ab5-64f9-1fc7-9d0d-ef41b8f7630a", "code": "A10BD22", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin and evogliptin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD22&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "9b117962-3185-6ab7-ae4d-07e2560bb93d", "code": "616117", "comments": "ORPHAN DRUG|Designated|Treatment of progressive myoclonus epilepsy type 2 (Lafora disease)", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=616117", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "53ddbfd0-d9cf-ad8e-c442-fb6a86c91cec", "code": "C1892", "comments": "Pharmacologic Substance[C1909]|Chemopreventive Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1892", "code_system": "NCI_THESAURUS", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "b94db1e7-c212-2eac-9dc8-852f2958bf28", "code": "C98234", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Digestive System or Metabolism[C78276]|Anti-diabetic Agent[C29711]|Biguanide Antidiabetic Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C98234", "code_system": "NCI_THESAURUS", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "50a6c565-b8bb-46c8-c5b7-059d71915eb7", "code": "A10BD25", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES|BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|Combinations of oral blood glucose lowering drugs|metformin, saxagliptin and dapagliflozin", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A10BD25&showdescription=yes", "code_system": "WHO-ATC", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "71bd0ada-ebce-86f4-edcd-06ccf27fa079", "code": "EU/3/17/1965", "comments": "EU ORPHAN DRUG|Positive|Treatment of Duchenne muscular dystrophy", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3171965", "code_system": "EU-Orphan Drug", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "628755ff-696a-44d7-926a-ac5784a7027d", "code": "9100L32L2N", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "06f5024e-f2f0-4557-682b-543f5627a207", "code": "1725", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/1725", "code_system": "DRUG CENTRAL", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "e999b6f4-e700-69bf-dcd6-d63dc840aca0", "code": "6801", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:6801", "code_system": "CHEBI", "references": [ "cbc66753-ff32-6272-7901-9aa8436104e8" ] }, { "uuid": "807ca553-ed19-276c-d243-814e3ed6527c", "code": "9100L32L2N", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=9100L32L2N", "code_system": "DAILYMED", "references": [ "19871854-d844-4d1e-b6e6-8218ab5afedf" ] }, { "uuid": "ebabb537-b6fb-5202-d5ea-60b36a895895", "code": "100000085448", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "b4369ff2-b454-fd74-60dc-41534228fdf9" ] }, { "uuid": "89500815-1be3-72ba-9f55-1b1050cb4df2", "code": "432214", "comments": "ORPHAN DRUG|Designated/Withdrawn|Treatment of pediatric polycystic ovary syndrome", "codeText": "ORPHAN DRUG|Designated/Withdrawn|Treatment of pediatric polycystic ovary syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=432214", "code_system": "FDA ORPHAN DRUG" } ], "substance_class": "chemical", "references": [ { "uuid": "2246135f-037e-4b17-90cf-1b62f081e91a", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "e91ccfc1-de33-4e2f-be54-22a05fea1b6a", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c517f057-2cb7-4395-bf25-1e73bb7711e2", "citation": "INN Proposed List 21", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL21.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "5998a9f3-d5cf-483f-9173-493522a900e0", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5a74a5bb-9e01-4801-96b4-6e50212912fd", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d5402756-677f-4386-aaf8-56737186e867", "citation": "EMPIRICA", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fcafbe54-9410-4332-a1dd-f5c4e95b3c33", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0d5b69a9-d703-42cb-b607-495f5ba28a39", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8ef15da9-330c-4ea7-830f-8becdaee8724", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389711000, "tags": [ "NOMEN" ] }, { "uuid": "0b0d4cc6-9fbf-4558-a3e7-5280d0d1209c", "citation": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4594abca-a1f6-49eb-9129-59cc5d0ff053", "url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4594abca-a1f6-49eb-9129-59cc5d0ff053", "doc_type": "FDA APPROVED DRUG LABEL", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fd225dcd-ad26-4a45-9595-70e539a5aaee", "citation": "SRS import [9100L32L2N]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=9100L32L2N", "doc_type": "SRS", "public_domain": true, "document_date": 1493389711000, "tags": [ "NOMEN" ] }, { "uuid": "340692bf-ed6e-4913-960f-c650a96efb37", "citation": "METFORMIN [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c8ff89fb-a078-4b95-b9c5-5d78b00da88a", "citation": "METFORMIN [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "95d002f0-ec09-4b32-9a34-8a2af557bcc6", "citation": "METFORMIN [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c9d88e9e-8873-4c25-a694-9afb4eb15364", "citation": "METFORMIN [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "ed811346-5c7d-46d7-b857-c5f2cc8406f6", "citation": "METFORMIN [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e6382dbf-fe4b-2927-26ba-0d9e262c63c0", "citation": "Nakamichi, Noritaka, et al. \"Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin.\" Journal of pharmaceutical sciences 102.9 (2013): 3407-3417.", "doc_type": "JA", "public_domain": true }, { "uuid": "2a131d91-c13f-011c-be34-f61ecd0a1fc2", "citation": "Biochemical Pharmacology\nVolume 74, Issue 2, 15 July 2007, Pages 359-371", "url": "http://www.sciencedirect.com/science/article/pii/S0006295207002298?via%3Dihub", "doc_type": "JA", "public_domain": true }, { "uuid": "5bc41add-c905-c2eb-4bca-fa72e83fdc42", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=657-24-9", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "6c7fbb1d-8a58-5777-b952-d5a3edf6180b", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+657-24-9", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "916a20e1-ccbe-14eb-6f6a-b8b0302e4217", "citation": "Kimura, Naoko, et al. \"Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.\" Drug metabolism and pharmacokinetics 20.5 (2005): 379-386.", "url": "https://www.sciencedirect.com/science/article/pii/S1347436715307758", "doc_type": "JA", "public_domain": true }, { "uuid": "126037ef-6875-9a9e-2040-f3badbb72e43", "citation": "Wang, De-Sheng, et al. \"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.\" Journal of Pharmacology and Experimental Therapeutics 302.2 (2002): 510-515.", "url": "http://jpet.aspetjournals.org/content/302/2/510.short", "doc_type": "JA", "public_domain": true }, { "uuid": "b4369ff2-b454-fd74-60dc-41534228fdf9", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "51f10006-95be-c36f-a33f-84702774f900", "citation": "METFORMIN", "doc_type": "MICROMEDEX", "public_domain": true }, { "uuid": "cbc66753-ff32-6272-7901-9aa8436104e8", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "30007789-8725-4812-8e59-f300fe907714", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "a2705e73-5252-4ca4-a569-7322a94fb28c", "citation": "IM156", "url": "https://www.medchemexpress.com/im156.html", "doc_type": "MANUFACTURER PRODUCT DESCRIPTION", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "3948e8df-001c-44f6-a1ae-e4ca67cab1aa", "citation": "Liang, Xiaomin, and Kathleen M. Giacomini. \"Transporters involved in metformin pharmacokinetics and treatment response.\" Journal of pharmaceutical sciences 106.9 (2017): 2245-2250.", "url": "https://www.sciencedirect.com/science/article/pii/S0022354917303519", "doc_type": "JA", "public_domain": true }, { "uuid": "19871854-d844-4d1e-b6e6-8218ab5afedf", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "d1898a46-1a66-c3bc-571b-c33f53b79449", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "2e3d8961-2f34-4556-b37c-5b7ba5ce8a87", "id": "2e3d8961-2f34-4556-b37c-5b7ba5ce8a87", "molfile": "\n Marvin 01132102292D \n\n 9 8 0 0 0 0 999 V2000\n 3.5706 -1.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8467 -0.8326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8467 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1279 -1.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1279 -2.0503 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4221 -0.8170 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7058 -1.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -0.8144 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7058 -2.0581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 3 2 1 0 0 0 0\n 2 4 1 0 0 0 0\n 5 4 2 0 0 0 0\n 6 4 1 0 0 0 0\n 7 6 1 0 0 0 0\n 8 7 1 0 0 0 0\n 9 7 2 0 0 0 0\nM END", "smiles": "CN(C)C(=N)NC(=N)N", "formula": "C4H11N5", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "96ca6800-a2f1-4452-8837-33a712508779" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "129.1638", "optical_activity": "NONE", "stereo_centers": 0 } ], "definition_level": "COMPLETE", "uuid": "2fb5e634-ee9f-4b48-abe5-99b91fe3d91c", "version": "43", "structure": { "id": "09c7274a-8b28-45b4-9775-e85fc8622f58", "molfile": "\n Marvin 01132100462D \n\n 9 8 0 0 0 0 999 V2000\n 2.1279 -1.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4221 -0.8170 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7058 -1.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1279 -2.0503 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8467 -0.8326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -0.8144 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7058 -2.0581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5706 -1.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8467 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 2 1 0 0 0 0\n 4 1 2 0 0 0 0\n 5 1 1 0 0 0 0\n 6 3 2 0 0 0 0\n 7 3 1 0 0 0 0\n 8 5 1 0 0 0 0\n 9 5 1 0 0 0 0\nM END", "smiles": "CN(C)C(=N)NC(=N)N", "formula": "C4H11N5", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "129.1638", "optical_activity": "NONE", "references": [ "2246135f-037e-4b17-90cf-1b62f081e91a", "fd225dcd-ad26-4a45-9595-70e539a5aaee", "c517f057-2cb7-4395-bf25-1e73bb7711e2" ], "stereo_centers": 0 }, "unii": "9100L32L2N", "relationships": [ { "uuid": "7396e47c-9268-48be-825e-c50a3c90605c", "amount": { "uuid": "c139e88d-b5c9-420c-b502-14b49e030eaf" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "89ff797b-8141-46de-a3be-15039bc13610", "refuuid": "2fb5e634-ee9f-4b48-abe5-99b91fe3d91c", "name": "Metformin", "unii": "9100L32L2N", "linking_id": "9100L32L2N", "ref_pname": "Metformin", "substance_class": "reference" } }, { "uuid": "0419dc9b-3535-4e8e-821d-d62a8801841d", "amount": { "uuid": "9710693e-16c1-4c1f-9893-5f152c9f2287" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "8d097695-25fc-4385-9e81-7c1e249f2c95", "refuuid": "27d79849-021d-40db-a495-52c707037776", "name": "Metformin hydrochloride", "unii": "786Z46389E", "linking_id": "786Z46389E", "ref_pname": "Metformin hydrochloride", "substance_class": "reference" } }, { "uuid": "4d42845f-9545-43e4-a537-af899251d59e", "amount": { "uuid": "6f6e189f-a9a0-4d82-b5f9-1316eb4dc36c" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "e77b8816-b334-436d-a7b7-c9a233423f6c", "refuuid": "b4fba2d6-aef3-4761-8f36-4fc537fd017b", "name": "METFORMIN OROTATE", "unii": "KE1D8AP3J5", "linking_id": "KE1D8AP3J5", "ref_pname": "METFORMIN OROTATE", "substance_class": "reference" } }, { "uuid": "ea98e9ec-148b-45f8-9ed0-bb726fe0f624", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "ff0c2238-4f38-40e5-bdcc-89cc017be94a", "refuuid": "f9103c06-2376-423e-8e3d-143f333e9627", "name": "METFORMIN P-CHLOROPHENOXYACETATE", "unii": "ECS8EBF633", "linking_id": "ECS8EBF633", "ref_pname": "METFORMIN P-CHLOROPHENOXYACETATE", "substance_class": "reference" } }, { "uuid": "e0e0e63b-6a6b-4f5c-b320-63b5990ecfc2", "amount": { "uuid": "8eee54f5-99c9-4705-9967-23492873b93d", "type": "RELATIONSHIP_AMOUNT", "average": 100, "units": "MOLE PERCENT OF AMOUNT ADMINISTERED" }, "qualification": "URINE", "type": "EXCRETED UNCHANGED", "references": [ "0b0d4cc6-9fbf-4558-a3e7-5280d0d1209c" ], "related_substance": { "uuid": "2320e387-7286-45a8-a5a2-776f7257bfd9", "refuuid": "2fb5e634-ee9f-4b48-abe5-99b91fe3d91c", "name": "Metformin", "unii": "9100L32L2N", "linking_id": "9100L32L2N", "ref_pname": "Metformin", "substance_class": "reference" } }, { "uuid": "81333e80-8ffd-4161-a5de-e71803a39f6b", "type": "TRANSPORTER->SUBSTRATE", "references": [ "126037ef-6875-9a9e-2040-f3badbb72e43" ], "related_substance": { "uuid": "bbd34886-0e93-4d53-b54b-1b1df9af312c", "refuuid": "2f4a8b5a-edf6-42dc-92c9-44f5e2b84d02", "name": "OCT-1", "unii": "ONY583280Z", "linking_id": "ONY583280Z", "ref_pname": "OCT-1", "substance_class": "reference" } }, { "uuid": "6e57c757-c874-4125-8d3c-0235a0233b0b", "amount": { "uuid": "202f07f5-f874-446c-8b7d-bc2cfe700fef", "average": 780, "high": 790, "low": 770, "units": "MICROMOLAR" }, "qualification": "Km", "type": "TRANSPORTER->SUBSTRATE", "references": [ "2a131d91-c13f-011c-be34-f61ecd0a1fc2" ], "related_substance": { "uuid": "20e1027e-9428-4339-b7d5-49491b3976a3", "refuuid": "99b36ccf-a943-4908-9ec5-0851afa8046c", "name": "MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1", "unii": "6NP3XSMIP3", "linking_id": "6NP3XSMIP3", "ref_pname": "MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1", "substance_class": "reference" } }, { "uuid": "777a4119-ff84-478e-9700-4d53c7c53e07", "amount": { "uuid": "1f041e2a-26b1-4867-ace8-22adaae2f414", "average": 4.46, "high": 5.05, "low": 3.87, "units": "nM/min/mg protein" }, "qualification": "Vmax", "type": "TRANSPORTER->SUBSTRATE", "references": [ "2a131d91-c13f-011c-be34-f61ecd0a1fc2" ], "related_substance": { "uuid": "76763084-fa7d-436b-a49d-27893126317c", "refuuid": "99b36ccf-a943-4908-9ec5-0851afa8046c", "name": "MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1", "unii": "6NP3XSMIP3", "linking_id": "6NP3XSMIP3", "ref_pname": "MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1", "substance_class": "reference" } }, { "uuid": "6dc48125-f8c3-4c08-8af0-f2ba28af8800", "amount": { "uuid": "2491a4b7-a881-4173-85c8-dd38953d08f4", "average": 1980, "high": 2478, "low": 1500, "units": "MICROMOLAR" }, "qualification": "Km", "type": "TRANSPORTER->SUBSTRATE", "references": [ "2a131d91-c13f-011c-be34-f61ecd0a1fc2" ], "related_substance": { "uuid": "490ac57f-f1df-4687-98c4-cf4d031c3b74", "refuuid": "14a4690b-45b6-455e-b530-a8ffd7dc8184", "name": "MATE-2", "unii": "B46KUN2O9L", "linking_id": "B46KUN2O9L", "ref_pname": "MATE-2", "substance_class": "reference" } }, { "uuid": "bfe38f95-2570-4879-9971-065d22b90601", "amount": { "uuid": "932ae1b6-55fd-41f7-b2db-88bac238cf5f", "average": 1.69, "high": 2.03, "low": 1.35, "units": "nM/min/mg protein" }, "qualification": "Vmax", "type": "TRANSPORTER->SUBSTRATE", "references": [ "2a131d91-c13f-011c-be34-f61ecd0a1fc2" ], "related_substance": { "uuid": "9879623a-3dd7-4cbd-a0e7-3f4e1ba6a0c2", "refuuid": "14a4690b-45b6-455e-b530-a8ffd7dc8184", "name": "MATE-2", "unii": "B46KUN2O9L", "linking_id": "B46KUN2O9L", "ref_pname": "MATE-2", "substance_class": "reference" } }, { "uuid": "7320aaf3-cc10-4347-8772-88c0543de6f4", "type": "TRANSPORTER->SUBSTRATE", "related_substance": { "uuid": "bba829f9-fc3f-4385-97c3-695eb2c871f8", "refuuid": "0c314c2f-d564-4480-a573-29f064d1ac3b", "name": "OCT-2", "unii": "482M00274D", "linking_id": "482M00274D", "ref_pname": "OCT-2" } }, { "uuid": "065b6a03-fa5d-44e7-8655-01d6ee6b1d87", "type": "TRANSPORTER->SUBSTRATE", "references": [ "e6382dbf-fe4b-2927-26ba-0d9e262c63c0" ], "related_substance": { "uuid": "088d7258-df69-45f2-a1f9-7084e9e26aab", "refuuid": "bae2067e-1587-4c4c-9478-3e5187ded9fa", "name": "OCTN-1", "unii": "515ZW3T4Z5", "linking_id": "515ZW3T4Z5", "ref_pname": "OCTN-1", "substance_class": "reference" } }, { "uuid": "a85b1454-a4e9-4a35-a4ea-14f58ae979aa", "amount": { "uuid": "e56ecff2-e055-4384-b101-db676dbed8f8" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "6e12d59c-98b6-40b8-af9d-0b8b13724353", "refuuid": "af9ffd4a-2fca-4281-a678-fc27e5b8b9b4", "name": "METFORMIN GLYCINATE", "unii": "YEI21W005Y", "linking_id": "YEI21W005Y", "ref_pname": "METFORMIN GLYCINATE", "substance_class": "reference" } }, { "uuid": "ffcb4eb8-8f1d-4ada-89d9-466cccb69c3b", "amount": { "uuid": "1bac4038-dcad-4303-9d7d-76e6d1d4a707" }, "type": "DERIVATIVE->PARENT", "references": [ "a2705e73-5252-4ca4-a569-7322a94fb28c" ], "related_substance": { "uuid": "b597a10b-a5ba-4370-847e-ad23e61e8d53", "refuuid": "784fc9ba-1948-4fdf-ae47-a5d6feddf386", "name": "Lixumistat", "unii": "4G3BUV6ZSK", "linking_id": "4G3BUV6ZSK", "ref_pname": "Lixumistat" } }, { "uuid": "8f6f6e2e-1c1f-4e69-8607-b2e3adaffcbb", "amount": { "uuid": "4c018575-21e5-4798-ad9c-e2d682d63014", "average": 1150, "units": "MICROMOLAR" }, "qualification": "Km", "type": "TRANSPORTER->SUBSTRATE", "references": [ "3948e8df-001c-44f6-a1ae-e4ca67cab1aa" ], "related_substance": { "uuid": "951d7c19-cd9a-4bdd-a6af-a6eeb32ae710", "refuuid": "9ec3df92-2586-4b3f-a181-0bf5c21e1152", "name": "THIAMINE TRANSPORTER 2", "unii": "Y83809589C", "linking_id": "Y83809589C", "ref_pname": "THIAMINE TRANSPORTER 2", "substance_class": "reference" } } ], "names": [ { "uuid": "23c64565-80f6-41dd-9133-3c7e0500e49f", "name": "1,1-Dimethylbiguanide", "stdName": "1,1-DIMETHYLBIGUANIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "e91ccfc1-de33-4e2f-be54-22a05fea1b6a" ], "display_name": false }, { "uuid": "aa058f1a-8c9c-4159-b705-e52db034f336", "name": "IMIDODICARBONIMIDIC DIAMIDE, N,N-DIMETHYL-", "stdName": "IMIDODICARBONIMIDIC DIAMIDE, N,N-DIMETHYL-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "e91ccfc1-de33-4e2f-be54-22a05fea1b6a" ], "display_name": false }, { "uuid": "483a731b-94ca-4c68-b84d-7baef815259e", "name": "METFORMIN EXTENDED RELEASE", "stdName": "METFORMIN EXTENDED RELEASE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d5402756-677f-4386-aaf8-56737186e867" ], "display_name": false }, { "uuid": "0e82e4bf-84a7-4298-ac82-f6874a779e59", "name": "METFORMIN [MI]", "stdName": "METFORMIN [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5a74a5bb-9e01-4801-96b4-6e50212912fd" ], "display_name": false }, { "uuid": "237a7277-51c0-4171-92a7-bbf105961fe2", "name": "METFORMIN [USAN]", "stdName": "METFORMIN [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5998a9f3-d5cf-483f-9173-493522a900e0" ], "display_name": false }, { "uuid": "0e7269fb-b0f0-4b3a-82ba-cc6b43817ce1", "name": "METFORMIN [VANDF]", "stdName": "METFORMIN [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0d5b69a9-d703-42cb-b607-495f5ba28a39" ], "display_name": false }, { "uuid": "207d211c-3eb3-4b9d-8484-46ef57979707", "name": "Metformin", "stdName": "METFORMIN", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "c517f057-2cb7-4395-bf25-1e73bb7711e2", "340692bf-ed6e-4913-960f-c650a96efb37", "ed811346-5c7d-46d7-b857-c5f2cc8406f6", "c9d88e9e-8873-4c25-a694-9afb4eb15364", "fcafbe54-9410-4332-a1dd-f5c4e95b3c33", "5a74a5bb-9e01-4801-96b4-6e50212912fd", "2246135f-037e-4b17-90cf-1b62f081e91a", "95d002f0-ec09-4b32-9a34-8a2af557bcc6", "5998a9f3-d5cf-483f-9173-493522a900e0", "c8ff89fb-a078-4b95-b9c5-5d78b00da88a", "0d5b69a9-d703-42cb-b607-495f5ba28a39" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "18768811-d22a-4465-a66a-06e027d8241a", "name_org": "INN" }, { "uuid": "726377f8-c285-43bc-b358-3c7f459b9346", "name_org": "USAN" } ] }, { "uuid": "a486069a-c563-7cc1-821b-a45046c93cc4", "name": "Metformin [WHO-DD]", "stdName": "METFORMIN [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d1898a46-1a66-c3bc-571b-c33f53b79449" ], "display_name": false }, { "uuid": "f4ded738-482f-4c4b-9d41-32fd86c2eff3", "name": "metformin [INN]", "stdName": "METFORMIN [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c517f057-2cb7-4395-bf25-1e73bb7711e2" ], "display_name": false } ], "properties": [ { "uuid": "a75c9c20-db15-4e1e-8835-93334a133e1a", "name": "MAXIMUM TOLERATED DOSE", "value": { "uuid": "e1a9128b-1774-400f-9091-bc7b212aae01", "average": 2550, "units": "mg/day", "non_numeric_value": "IMMEDIATE-RELEASE TABLETS, ORAL SOLUTION" }, "defining": false, "parameters": [ { "uuid": "6677db5b-1098-493b-9370-a9a3eb023eed", "name": "FORTAMET", "value": { "uuid": "f2724af6-369d-4cae-a4fb-d470572b9c12", "average": 2500, "units": "mg/day", "references": [], "non_numeric_value": "EXTENDED-RELEASE" }, "references": [] }, { "uuid": "e33baad4-c32a-4364-bd7a-6d0ca79a1b2f", "name": "GLUCOPHAGE XR, GLUMETZA", "value": { "uuid": "b2a0a326-601a-4cc0-a83a-c8a724854dc0", "average": 2000, "units": "mg/day", "references": [], "non_numeric_value": "EXTENDED-RELEASE" }, "references": [] } ], "property_type": "TOXICITY", "references": [ "51f10006-95be-c36f-a33f-84702774f900" ] }, { "uuid": "d963fb36-7bf1-4845-b836-741e1580a9c2", "name": "ORAL BIOAVAILABILITY", "value": { "uuid": "6782590c-6f78-49fb-adc0-429b12f42719", "type": "MOLE PERCENT OF AMOUNT ADMINISTERED", "high": 60, "low": 50, "units": "%" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "51f10006-95be-c36f-a33f-84702774f900" ] }, { "uuid": "120e913e-7409-4d64-8914-c88c07419ebe", "name": "Tmax", "value": { "uuid": "526e8f3a-30f9-4634-baf5-f837ec52d12b", "high": 4.1, "low": 1.79, "non_numeric_value": "IMMEDIATE-RELEASE, ORAL" }, "defining": false, "parameters": [ { "uuid": "dce7bbf8-96c4-42d6-8198-d97c1a89ef56", "name": "ORAL, EXTENDED-RELEASE", "type": "PHARMACOKINETIC", "value": { "uuid": "01dcfdfa-f601-4ec6-8029-64f7c96952bd", "high": 8, "low": 6, "units": "hours", "references": [] }, "references": [] }, { "uuid": "bbc1b2f3-3369-4782-a1ba-e13ec75214c8", "name": "ORAL, GERIATRIC", "type": "PHARMACOKINETIC", "value": { "uuid": "bb89ed5f-9761-493a-8fe2-98c84fcaea10", "average": 2.71, "units": "hours", "references": [] }, "references": [] }, { "uuid": "97f22db3-1f90-4fdb-a2d6-c2f43dcf1d99", "name": "ORAL, RENAL IMPAIRMENT", "type": "PHARMACOKINETIC", "value": { "uuid": "d36d60e6-ebb0-4ce0-99a9-442d5e19cde9", "high": 4.01, "low": 3.2, "units": "hours", "references": [] }, "references": [] }, { "uuid": "34b3558f-61ce-4887-b843-2b0364a2e149", "name": "ORAL, PREGNANCY", "type": "PHARMACOKINETIC", "value": { "uuid": "b56cc8ce-1b41-4206-ae35-bb2e98454243", "high": 2, "low": 1, "units": "hours", "references": [] }, "references": [] } ], "property_type": "PHARMACOKINETIC", "references": [ "51f10006-95be-c36f-a33f-84702774f900" ] }, { "uuid": "562ef906-443d-489c-8ecd-02261d7aa075", "name": "Volume of Distribution", "value": { "uuid": "890a215e-703d-4f40-b600-deff4df543c2", "average": 654, "units": "LITERS" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "51f10006-95be-c36f-a33f-84702774f900" ] }, { "uuid": "6968403c-bb2b-46d6-97d4-31198f50348d", "name": "Biological Half-life", "value": { "uuid": "330da2f5-b661-4eca-8d29-ab1be8dc6de5", "high": 6.2, "low": 5.4, "units": "hours" }, "defining": false, "parameters": [ { "uuid": "67428fdc-918e-4908-9bf2-ca2ceefb67cd", "name": "GERIATRIC", "value": { "uuid": "ec52a59e-8bc2-4d8d-b2e5-f0db0545f767", "references": [], "non_numeric_value": "PROLONGED BY 64%" }, "references": [] } ], "property_type": "PHARMACOKINETIC", "references": [ "51f10006-95be-c36f-a33f-84702774f900" ] } ] } ] }